Ainnocence is a next-generation biotech aiming to create a self-evolving modularized intelligent platform that integrates various advanced computational and wet lab technologies to revolutionize the drug discovery and development process. We leverage the AI drug discovery system to tackle the most difficult medical problems of the world. The founding team is a group of engineers and scientists with interdisciplinary education and industry backgrounds such as artificial intelligence, medicinal chemistry, structural biology, biomedical engineering, and pharmaceutical science. Our approach combines multi-system integration for whole R&D automation, multi-modality strategy for precision drug design, and ultra-large-scale virtual screening. Together we make great truths simple!